OTC · Financial Statements

Defence Therapeutics Inc. (DTCFF) Financial Statements

$0.29 OTC: DTCFF Market Cap $22.25M

Defence Therapeutics Inc. most recently reported annual revenue of $0, net profit of $-4.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-7.0M$-6.0M$-13.0M$-3.0M
Net Profit$-3.0M$-7.0M$-7.0M$-13.0M$-4.0M
EPS$-0.11$-0.20$-0.17$-0.30$-0.05
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.0M$1.0M$4.0M$0$2.0M
Total Liabilities$0$1.0M$2.0M$4.0M$3.0M
Cash$5.0M$1.0M$3.0M$0$1.0M
Borrowings$0$0$2.0M$2.0M$2.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-6.0M$-8.0M$-4.0M$-3.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$3.0M$0$-1.0M$0$0
Net Cash Flow$4.0M$-5.0M$2.0M$-3.0M$1.0M
Free Cash Flow$-2.0M$-6.0M$-8.0M$-4.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.09
EV / EBITDA-4.82
FCF Yield-12.29%
Quick Ratio3.37
Interest Coverage-20.51
Return 1Y-47.64%
Return 3Y-88.19%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
DTCFF Overview DTCFF Dividend Run Stock Screener